Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2005 by Xcyte Therapies.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Xcyte Therapies
ClinicalTrials.gov Identifier:
NCT00081783
First received: April 20, 2004
Last updated: June 23, 2005
Last verified: March 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given